Behandeling & zorg
alles tonen-
New Phase 2 Data on Bezisterim for the Treatment of Long COVID
-
BioVie shares Phase 2 bezisterim data for Long COVID treatment
-
Among Long COVID patients with the most fatigue, scores improved 8.93 points with BioVie’s drug vs 5.30 with placebo.
-
BioVie says bezisterim eased fatigue and cognitive symptoms in Long COVID subgroups
-
Electroacupuncture May Retune the Vagus Nerve to Calm Long COVID Inflammation
-
Probiotic VSL#3 Eases Long COVID Fatigue in Randomized Trial
-
Journal retracts, republishes paper on Long COVID treatment trial
-
COVID-19 may damage the brain’s dopamine system, new study
-
BioVie to present Phase 2 trial results of bezi...
-
BioVie to Present New Bezisterim Findings in Parkinson’s Disease and Long COVID at the 2026 American Neurological Association Annual MeetingOok bij:
proactiveinvestors.com -
Invivyd launches phase 2 trial of VYD2311 for long COVID By Investing.com
-
Invivyd and the SPEAR Study Group Announce Initiation of 'FLINTLOCK” Phase 2 Study of VYD2311, a Monoclonal Antibody for the Potential Treatment of Long COVID or Post-Vaccination SyndromeOok bij:
app.dealroom.co -
Can COVID still affect your brain after recovery?
-
Long COVID Diagnostic Score Under Fire: Researchers Warn Validation Study Overstates Accuracy
-
Trans people with Long COVID navigate a new “dark age” in trans health
-
Could Covid Reactivate Hidden Viruses in Your Body? Scientists Sound the Alarm
-
People with long COVID have an altered oral microbiome
-
Black healthcare workers who bore pandemic’s unequal burden need better long COVID support
-
Long COVID: Mouth And Lung Bacteria May Offer Clues
-
Long-COVID symptoms may be linked to bacterial mix in the mouth, lungs
-
Long COVID Linked With Altered Airway Microbiome
-
Five Seemingly Unrelated Illnesses May Share Faulty Genetic Wiring
-
A simple handgrip test offers new clues about long COVID
-
Long Covid severity linked to changes in mouth and lung bacteria, study findsOok bij:
inshorts.com
